In summary, PPH combined with PTX effectively inhibited the in vivo growth of PTX-resistant breast cancer, and its mechanism may be closely related to the downregulation of tumor cholesterol levels and the inhibition of lipid raft-associated transporter protein expression. This evidence concerns the gene ENO1 and breast cancer.